alexa Abstract | Comparative bacteriostatic potentials of oral paediatric antibiotics sold in two countries Running head: antibiotics from different countries

Archives of Clinical Microbiology
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Abstract

Background: Relationship between antibiotic use and emergence of resistance is complex; however, antibiotic misuse in clinical practices alone cannot explain the high frequency of antibiotic resistant bacteria in developing countries.Methods: Comparative bacteriostatic potentials of oral paediatric anti- biotics sold in Nigeria and Dubai were determined on 83 diarrhoea- genic bacterial strains, using modified agar well-diffusion method. Findings: Highest overall in vitro percentage resistance were 60.0- 91.7% against Safetum [cefpodoxime proxetil 240 mg N11], sold in Nigeria, while Septrin 240 mg [sulfamethoxazole + trimethoprim 240 mg D1] (33.3-71.4%) and Cefodox [cefpodoxime proxetil 100 mg D3] (54.5-75.0%) sold in Dubai were the most-resisted. Lowest overall resistance were displayed against Augmentin [amoxicillin + clavulanate potassium 228 mg N14] (0.0-10.0%) sold in Nigeria but Megamox [amoxicillin + clavulanic acid 228 mg D4 and 156 mg D6] (0.0-8.3% and 0.0-17.1%) sold in Dubai, were the least-resisted. Relatively wid- er zones of inhibition were recorded for paediatric antibiotics sold in Dubai. Nigerian-sold Tambac 50 mg [N4] and Safetum 240 mg [N11], manufactured in India and of the same active ingredients (cef- podoxime proxetil) exhibited significantly different resistance profiles of 9.1-41.7% and 60.0-91.7% respectively. Two amoxicillin derivatives sold in Nigeria, Amoxigram (amoxicillin) 250 mg [N12], manufactured in Malaysia and Augmentin (amoxicillin + clavulanate) 228 mg [N14]. manufactured in UK exhibited different resistance profiles of 13.3- 33.3% and 0.0-10.0% respectively. Sold in Dubai amoxicillin derivative antibiotics- Megamox 228 mg [D4] and 156 mg [D6], manufactured in Saudi Arabia exhibited 0.0-8.3% and 0.0-17.1% respectively, while Neomox 250 mg [D5] and 125 mg [D7], manufactured in United Arab Emirates exhibited 9.1-28.6% and 9.1-50.0% resistance respectively.Conclusion: Place of manufacture and place of purchase of antibiotics can contribute to the globally reported high prevalence of antibiotic resistance.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Ogunshe Adenike AO

Keywords

Ebola Virus Disease, Rotavirus Infection

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords